376 related articles for article (PubMed ID: 7680056)
21. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of basophil histamine release by interleukin-3: reduced effect in atopic subjects.
Miadonna A; Salmaso C; Cottini M; Milazzo N; Tedeschi A
Allergy; 1996 Aug; 51(8):525-31. PubMed ID: 8874655
[TBL] [Abstract][Full Text] [Related]
23. Histamine releasability of basophils and skin mast cells in chronic urticaria.
Zuberbier T; Schwarz S; Hartmann K; Pfrommer C; Czarnetzki BM
Allergy; 1996 Jan; 51(1):24-8. PubMed ID: 8721524
[TBL] [Abstract][Full Text] [Related]
24. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
25. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
[TBL] [Abstract][Full Text] [Related]
26. The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation.
Mochizuki A; McEuen AR; Buckley MG; Walls AF
J Allergy Clin Immunol; 2003 Jul; 112(1):102-8. PubMed ID: 12847486
[TBL] [Abstract][Full Text] [Related]
27. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
[TBL] [Abstract][Full Text] [Related]
28. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
29. IgG-, IgA-, and IgE-induced release of leukotriene C4 by monocytes isolated from patients with atopic dermatitis.
Ferreri NR; Zeiger RS; Spiegelberg HL
J Allergy Clin Immunol; 1988 Oct; 82(4):556-67. PubMed ID: 2844875
[TBL] [Abstract][Full Text] [Related]
30. Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy.
Moneret-Vautrin DA; Sainte-Laudy J; Kanny G; Frémont S
Ann Allergy Asthma Immunol; 1999 Jan; 82(1):33-40. PubMed ID: 9988204
[TBL] [Abstract][Full Text] [Related]
31. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli.
Warner JA; Peters SP; Lichtenstein LM; Hubbard W; Yancey KB; Stevenson HC; Miller PJ; MacGlashan DW
J Leukoc Biol; 1989 Jun; 45(6):558-71. PubMed ID: 2470847
[TBL] [Abstract][Full Text] [Related]
32. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
33. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis.
Butler JM; Chan SC; Stevens S; Hanifin JM
J Allergy Clin Immunol; 1983 May; 71(5):490-7. PubMed ID: 6188771
[TBL] [Abstract][Full Text] [Related]
34. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
Mendoza GR; Minagawa K; Orner FB; Stiehm ER
Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
[TBL] [Abstract][Full Text] [Related]
35. Extracellular signal-regulated kinases regulate leukotriene C4 generation, but not histamine release or IL-4 production from human basophils.
Miura K; Schroeder JT; Hubbard WC; MacGlashan DW
J Immunol; 1999 Apr; 162(7):4198-206. PubMed ID: 10201947
[TBL] [Abstract][Full Text] [Related]
36. Reduced priming effect of interleukin 3 on IgE mediated basophil histamine release in patients with systemic sclerosis.
Tedeschi A; Salmaso C; Milazzo N; Miadonna A
J Rheumatol; 1998 Jul; 25(7):1320-4. PubMed ID: 9676763
[TBL] [Abstract][Full Text] [Related]
37. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
[TBL] [Abstract][Full Text] [Related]
38. Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils.
Strenzke N; Grabbe J; Plath KE; Rohwer J; Wolff HH; Gibbs BF
Toxicol Appl Pharmacol; 2001 Aug; 174(3):257-63. PubMed ID: 11485386
[TBL] [Abstract][Full Text] [Related]
39. Human basophil releasability. III. Genetic control of human basophil releasability.
Marone G; Poto S; Celestino D; Bonini S
J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
[TBL] [Abstract][Full Text] [Related]
40. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
